10.21147/j.issn.1000-9604.2019.02.08
Weekly albumin-bound paclitaxel/cisplatin versus gemcitabine/cisplatin as first-line therapy for patients with advanced non-small-cell lung cancer: A phase Ⅱ open-label clinical study
31
2019-06-03(万方平台首次上网日期,不代表论文的发表时间)
共10页
339-348